This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (27)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Kristin A. Skinner, MD; Frederick R. Eilber, MD; E. Carmack Holmes, MD; Jeffrey Eckardt, MD; Gerald Rosen, MD

Arch Surg. 1992;127(9):1065-1071.

Abstract
• Between 1971 and 1991, 247 patients with stage I osteosarcoma were treated at UCLA. Patients were treated in four sequential groups, with group 1 receiving surgery alone, and groups 2 through 4 receiving various adjuvant chemotherapeutic regimens. The incidence of lung metastases in these patients decreased from 92% (group 1) to 31% (group 4), while the proportion of patients undergoing pulmonary resection increased (17% vs 82%). Overall 5-year survival rate among patients with pulmonary metastases increased from 0 in group 1 to 41 % (actuarial) in group 4. No clinical factor correlated significantly with outcome using univariate analysis, although there was a trend toward prolonged survival in those with longer disease-free intervals. Adjuvant chemotherapy and resection of pulmonary metastases have transformed a uniformly fatal condition into one with a reasonable expectation of long-term survival.

(Arch Surg. 1992;127:1065-1071)

Author Affiliations
From the Divisions of Surgical Oncology (Drs Skinner, Eilber, and Holmes) and Orthopedic Surgery (Dr Eckardt), UCLA School of Medicine; and Comprehensive Cancer Center, Cedars-Sinai Medical Center (Dr Rosen), Los Angeles. Dr Skinner is a recipient of a clinical oncology fellowship from the American Cancer Society.

Footnotes
Accepted for publication May 23, 1992.

Presented at the 63rd Annual Meeting of the Pacific Coast Surgical Association, Kauai, Hawaii, February 17, 1992.

Reprint requests to Division of Surgical Oncology, UCLA School of Medicine, 10833 Le Conte Ave, Los Angeles, CA 90024 (Dr Skinner).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Second and Subsequent Recurrences of Osteosarcoma: Presentation, Treatment, and Outcomes of 249 Consecutive Cooperative Osteosarcoma Study Group Patients
Bielack et al.
JCO 2009;27:557-565.
ABSTRACT | FULL TEXT  

Postrelapse Survival in Osteosarcoma of the Extremities: Prognostic Factors for Long-Term Survival
Ferrari et al.
JCO 2003;21:710-715.
ABSTRACT | FULL TEXT  

High-Dose Chemotherapy in the Treatment of Relapsed Osteosarcoma: An Italian Sarcoma Group Study
Fagioli et al.
JCO 2002;20:2150-2156.
ABSTRACT | FULL TEXT  

Osteogenic Sarcoma Presenting with Lung Metastasis
Staddon et al.
The Oncologist 2002;7:144-153.
ABSTRACT | FULL TEXT